Skip to main content
SpringerLink
Log in

Calciumantagonisten bei essentieller Hypertonie

  • Chapter
Book cover Calciumantagonisten

  • 25 Accesses

Zusammenfassung

Hypertonie ist in den Industrieländern einer der häufigsten Herz-Kreislauf-Risikofaktoren. Eine neulich durchgeführte Studie zeigte, daß in der Be: völkerung der Vereinigten Staaten jede vierte Person an Hypertonie leidet. Das Risiko, an einer Komplikation wie Myokardinfarkt, zerebrovaskulärem Insult, Herzinsuffizienz, terminaler Niereninsuffizienz oder peripherer Gefäßerkrankung zu erkranken, steht in direktem Verhältnis zur Höhe des Blutdruckes. Ungefähr 95% der Patienten mit erhöhtem Blutdruck haben eine sogenannte primäre oder essentielle Hypertonie. Eine Reihe von Mechanismen ist für die Pathogenese dieser Hochdruckform verantwortlich, und diese Vielfalt erklärt auch, warum verschiedene therapeutische Maßnahmen individuell sehr unterschiedlich wirksam sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (1993) Arch Intern Med 153: 154 - 182

    Article  Google Scholar 

  2. Guidelines for the Management of Mild Hypertension. Memorandum from a World Health Organization/International Society of Hypertension Meeting (1993) Hypertension 22: 392 - 403

    Google Scholar 

  3. Timmermans BMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, and Smith RD (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45: 205 - 251

    PubMed  CAS  Google Scholar 

  4. Williams RR, Hunt SC, Hasstedt SJ, Hopkins PN, Wu LL, Berry TD, Stults BM, Barlow GK, Schumacher MC, Lifton RP, and Lalouel JM (1991) Are there interactions and relations between genetic and environmental factors predisposing to high blood pressure? Hypertension 18 ( Suppl. I): 29 - 37

    Google Scholar 

  5. Morris BJ (1993) Identification of essential hypertension genes. J Hypertens 11: 115 - 120

    Article  PubMed  CAS  Google Scholar 

  6. Muntzel M, and Drücke T (1992) A comprehensive review of the salt and blood pressure relationship. Am J Hypertension 5:: 1S - 42S

    Google Scholar 

  7. Langford HG (1985) Dietary potassium and hypertension: epidemiologic data. Ann Intern Med 98: 770 - 772

    Google Scholar 

  8. Campese VM (1989) Calcium, parathyroid hormone and blood pressure. Am J Hypertens 2: 34S - 44S

    PubMed  CAS  Google Scholar 

  9. Reisin E (1990) Sodium and obesity in the pathogenesis of hypertension. Am J Hypertens 3: 164 - 167

    PubMed  CAS  Google Scholar 

  10. De Fronzo RA (1992) Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. J Cardiovasc Pharmacol 20 (Suppl 11): 1 - 16

    Article  Google Scholar 

  11. Mac Mahon SW, and Norton RN (1986) Alcohol and hypertension: Implications for prevention and treatment. Ann Intern Med 105: 124 - 126

    Google Scholar 

  12. Henry JP, and Grim CE (1990) Psychosocial mechanisms of primary hypertension. J Hypertension 8: 783 - 793

    Article  CAS  Google Scholar 

  13. Folkow B (1989) Sympathetic nervous control of blood pressure. Role in primary hypertension. Am J Hypertens 2: 1035 - 1115

    Google Scholar 

  14. Floras JS, and Hara K (1993) Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension. J Hypertension 11: 647 - 655

    Article  CAS  Google Scholar 

  15. Malliani A, Pagani M, Lombardi F, Furlan R, Guzzetti S, and Cerutti S (1993) Spectral analysis to assess increased sympathetic tone in arterial hypertension. Hypertension 17 ( Suppl. III ): 36 - 42

    Google Scholar 

  16. Ferrario CM, and Averill DB (1991) Do primary dysfunctions in neural control of arterial pressure contribute to hypertension? Hypertension 18 (Suppl. I): 38 - 51

    Google Scholar 

  17. Rosendorff C, Susanni E, Hurwitz ML, and Ross FP (1985) Adrenergic receptors in hypertension: radioligand binding studies. J Hypertension 3: 571 - 581

    Article  CAS  Google Scholar 

  18. Floras JS (1992) Epinephrine and the genesis of hypertension. Hypertension 19: 1 - 18

    PubMed  CAS  Google Scholar 

  19. Oparil S, and Haber E (1974) The renin-angiotensin system. N Engl Med 291: 389 - 401

    Article  CAS  Google Scholar 

  20. Erdös EG (1990) Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 16: 363 - 370

    PubMed  Google Scholar 

  21. Swales JD, and Heagerty AM (1987) Vascular renin-angiotensin system: the unanswered questions. J Hypertension 5 (Suppl. 2): 1 - 5

    Google Scholar 

  22. Zimmerman BG, Sybert EG, and Wong PC (1984) Interaction between sympathetic and renin-angiotensin system. J Hypertension 2: 581 - 588

    Article  CAS  Google Scholar 

  23. Carretero OA, and Scicli AG (1991) Local hormonal factors (intacrine, autocrine, and para-crine) in hypertension. Hypertension 18 (Suppl. I): 58 - 69

    Google Scholar 

  24. Bönner G, Preis S, Schunk U, Toussaint C, and Kaufmann W (1990) Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans. J Cardiovasc Pharmacol 15 (Suppl 6): 46 - 56

    Google Scholar 

  25. Mc Giff JC, Carroll MA, and Escalante B (1991) Arachidonate metabolites and kinins in blood pressure regulation. Hypertension 18 (Suppl. III): 150 - 157

    Google Scholar 

  26. Laragh JH (1985) Atrial natriuretic hormone, the renin-aldsterone axis and blood pressure electrolyte homeostasis. N Engl J Med 313: 1330 - 1332

    Article  PubMed  CAS  Google Scholar 

  27. Ganau A, Devereux RB, Atlas SA, Pecker M, Roman MY, Vargin RJ, Cody RJ, and Laragh JH (1989) Plasma atrial factor in essential hypertension: relation to cardiac size, function and systemic hemodynamics. J Am Coll Cardiol 14: 715 - 724

    Article  PubMed  CAS  Google Scholar 

  28. Ferrari P, Weidmann P, Ferrier CI, Dietler R, Hollmann R, Piso RJ, Wey J, and Shaw S (1990) Dysregulation of atrial natriuretic factor in hypertension-prone man. J Clin Endocrinol Metab 71: 944 - 951

    Article  PubMed  CAS  Google Scholar 

  29. Cinotti GA, and Pugliese F (1989) Prostaglandins and hypertension. Am J Hypertens 2: 10S - 15S

    PubMed  CAS  Google Scholar 

  30. Guyton AC (1989) Dominant role of the kidneys and accessory role of whole-body autoregulation in the pathogenesis of hypertension. Am J Hypertens 2: 575 - 585

    PubMed  CAS  Google Scholar 

  31. Hollenberg NK, and Williams GH (1989) Sodium-sensitive hypertension. Implications of pathogenesis for therapy. Am J Hypertens 2: 809 - 815

    PubMed  CAS  Google Scholar 

  32. Moncada S, Palmer RMJ, and Higgs EA (1991) Nitric oxyde: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109 - 142

    PubMed  CAS  Google Scholar 

  33. Vanhoutte PM (1993) Other endothelium-derived vasoactive factors. Circulation 87 (suppl V): 9 - 17

    Google Scholar 

  34. Panza JA, Quiyyumi AA, Brush JE Jr, and Eastein SE (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 2227

    Article  Google Scholar 

  35. Lüscher TF, Bong-gwan S, and Bühler FR (1993) Potential role of endothelin in hypertension. Controversy on endothelin in hypertension. Hypertension 21: 752-757

    Google Scholar 

  36. Blaustein MP (1977) Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment of a hypothesis. Am J Physiol 232: 165 - 173

    Google Scholar 

  37. Tonyz RM, and Schiffrin EL (1993) Signal transduction in hypertension: part I. Current Opinion in Nephrology and Hypertension 2: 5 - 16

    Article  Google Scholar 

  38. Tonyz R M, and Schiffrin EL (1993) Signal transduction in hypertension: part II. Current Opinion in Nephrology and Hypertension 2: 17 - 26

    Article  Google Scholar 

  39. Aviv A, and Lasker N (1992) Defects in membrane Transport of ions as possible pathogenic factors in hypertension. Current Opinion in Nephrology and Hypertension 1: 68 - 72

    Article  PubMed  CAS  Google Scholar 

  40. Folkow B (1982) Physiological aspects of primary hypertension. Physiol. Rev. 62: 347 - 504

    PubMed  CAS  Google Scholar 

  41. Diez J (1992) Cardiovascular growth associated with arterial hypertension. J Cardiovasc Pharmacol 20 (Suppl. B): 1 - 5

    Google Scholar 

  42. Stokes J, Kannel WB, Wolf PA, Cupples LA, and D’Agostino RB (1987) The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 75 ( Suppl. V): 65 - 73

    Google Scholar 

  43. Mac Mahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbot R, Godwin J, Dyer A, and Stamler J (1990) Blood pressure, stroke, and coronary heart disease. Part I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression, dilution bias. Lancet 335: 765 - 777

    Article  Google Scholar 

  44. Whelton PK, and Klag MJ (1989) Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence. Hypertension 13 (Suppl. I): 19 - 27

    Google Scholar 

  45. Hansson L (1992) The key issues in preventive cardiology. Blood Pressure 1 (Suppl. 4): 710

    Article  Google Scholar 

  46. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, Fouad-Tarazi F, Horan MJ, Marcus M, Massie B, Pfeffer MA, Re RN, Roccella EJ, Savage D, and Shub C (1992) The heart in hypertension. N Engl J Med 327: 998 - 1007

    Article  PubMed  CAS  Google Scholar 

  47. Ljungman S (1990) Microalbuminuria in essential hypertension. Am J Hypertens 3: 956 - 960

    PubMed  CAS  Google Scholar 

  48. Collins R, Peto R, Mac Mahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, and Hennekens CH (1990) Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 335: 827 - 838

    Article  PubMed  CAS  Google Scholar 

  49. Cutler JA, MacMahon SW, and Furberg CD (1989) Controlled clinical trials of drug treatment for hypertension. A review. Hypertension 13 (Suppl. I): 36 - 44

    Google Scholar 

  50. Mac Mahon S, and Rodgers A (1993) The effects of blood pressure reduction in older patients: An overview of five rendomized controlled trials in elderly hypertensives. Clin and Exper Hypertension 15: 967 - 978

    Article  Google Scholar 

  51. Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R, Lewis CE, and Liebson PR, for the Treatment of Mild Hypertension Study research Group (1993) Treatment of Mild Hypertension Study. Final results. JAMA 270: 713-724

    Google Scholar 

  52. Dahlöf B, Pennert K, and Hansson L (1992) Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hyperten 5: 95 - 110

    Google Scholar 

  53. Mimran A, and Ribstein J (1992) Antihypertensive therapy in renal disease and transplantation. J Hypertens 10 (Suppl. 5): 79 - 85

    Article  Google Scholar 

  54. Pickering TG (1992) Ambulatory monitoring and the definition of hypertension. J Hypertension 10: 401 - 409

    Article  CAS  Google Scholar 

  55. World Hypertension League (1988) Self-measurement of blood pressure: a statement by the World hypertension League. J Hypertension 6: 257 - 261

    Article  Google Scholar 

  56. Devereux RB, and Pickering TG (1990) Relationship between ambulatory or exercise blood pressure and left ventricular structure: prognostic implications. J Hypertension 8 (Suppl 6): 125 - 134

    Google Scholar 

  57. Hoegholm A, Bang LE, Kristensen KS, Nielson JW, and Holm J (1994) Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension 24: 101 - 105

    PubMed  CAS  Google Scholar 

  58. Verdecchia P, Schillacci G, Guerrieri M, Benemio G, Boldrini F, and Porcellati C (1990) Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81: 528 - 536

    Article  PubMed  CAS  Google Scholar 

  59. Imai Y, and Abe K (1993) Clinical significance of nocturnal blood pressure in the elderly. Cardiology in the Elderly 1: 483 - 489

    Google Scholar 

  60. Bianchi S, Bigazzi R, Baldari G, Sgherri G, and Campese VM (1994) Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 7: 23 - 29

    PubMed  CAS  Google Scholar 

  61. Kaplan NM (1991) Long-term effectiveness of non pharmacological treatment of hypertension. Hypertension 18 (Suppl. I): 153 - 160

    Google Scholar 

  62. Staessen J, Fagard R, Lijnen P, and Amery A (1989) Body weight, sodium intake and blood pressure. J Hypertens 7 (Suppl. 1): 19 - 23

    Article  Google Scholar 

  63. Gifford RW, and Borazanian RA (1989) Traditional first-line therapy. Overview of medical benefits and side effects. Hypertension 13 (Suppl. I): 119 - 124

    Google Scholar 

  64. Johnston CI (1993) The place of diuretics in the treatment of hypertension in 1993: Can we do better ? Clin Exp Hypertension 15: 1239 - 1255

    Article  CAS  Google Scholar 

  65. Man in’t Veld AJ, van den Meiracker A, and Schalekamp MADH (1986) The effect of beta-blockers on total peripheral resistance. J Cardiovasc Pharmacol 8 (Suppl. 4): 49 - 60

    Article  Google Scholar 

  66. Cruickshank JM (1992) The case for beta-blockers as first-line antihypertensive therapy. J Hypertens 10 (Suppl. 3): 21 - 27

    Article  Google Scholar 

  67. Brunner HR, Waeber B, and Nussberger J (1987) Treatment of hÿpertennion with ACE inhibition as first step: pharmacologic and clinical considerations. J Cardiovasc Pharmacol 10 (Suppl 7): S36 — S42

    Article  PubMed  Google Scholar 

  68. Williams GH (1989) Converting-enzyme inhibitors in the treatment of hypertension. N Engl J Med 319: 1517 - 1525

    Google Scholar 

  69. Dustan HP (1989) Calcium channel blockers. Potential medical benefits and side effects. Hypertension 13 (Suppl I): 37 - 40

    Google Scholar 

  70. Luft FC, and Haller H (1993) Calcium channel blockers in current, medical practice: An update for 1993. Clin Exp Hypertension 15: 1263 - 1276

    Article  CAS  Google Scholar 

  71. Yusuf S (1995) Calcium antagonists in coronary antery disease and hypertension. Time for revaluation? Circulation 92: 1079 - 1082

    PubMed  CAS  Google Scholar 

  72. Grimm RH (1989) Alphal-antagonists in the treatment of hypertension. Hypertension 13 (Suppl I): 131 - 136

    Google Scholar 

  73. Brunner HR, Ménard J, Waeber B, Burnier M, Biollaz J, Nussberger J, and Bellet M (1990) Treating the individual hypertensive patient: Considerations on dose, sequential monotherapy and fixed-dose combinations. J Hypertension 8: 3-11

    Google Scholar 

  74. Chalmers J (1993) The place of combination therapy in the treatment of hypertension in 1993. Clin Exp Hypertension 15: 1299 - 1313

    Article  Google Scholar 

  75. Ménard J (1993) Critical assessment of combination therapy development. Blood Pressure 2 (Suppl. 1): 5 - 9

    Google Scholar 

Download references

Authors
  1. B. Waeber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Bonvin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. R. Brunner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Innere Medizin III, Medizinische Universitätsklinik, Bergheimer Straße 58, 69115, Heidelberg, Deutschland

    Wolfgang Kübler

  2. Institut für Medizinische Physik und Biophysik, Harrachgasse 21, A-8010, Graz, Österreich

    Helmut A. Tritthart

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this chapter

Cite this chapter

Waeber, B., Bonvin, R., Brunner, H.R. (1996). Calciumantagonisten bei essentieller Hypertonie. In: Kübler, W., Tritthart, H.A. (eds) Calciumantagonisten. Steinkopff. https://doi.org/10.1007/978-3-642-93678-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93678-4_7

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-93679-1

  • Online ISBN: 978-3-642-93678-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation